IN2014DN08781A - - Google Patents

Info

Publication number
IN2014DN08781A
IN2014DN08781A IN8781DEN2014A IN2014DN08781A IN 2014DN08781 A IN2014DN08781 A IN 2014DN08781A IN 8781DEN2014 A IN8781DEN2014 A IN 8781DEN2014A IN 2014DN08781 A IN2014DN08781 A IN 2014DN08781A
Authority
IN
India
Prior art keywords
conjugates
particles
assemble
peptide
agents
Prior art date
Application number
Other languages
English (en)
Inventor
Ting Xu
He Dong
Jessica Shu
Nikhil Dube
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of IN2014DN08781A publication Critical patent/IN2014DN08781A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
IN8781DEN2014 2012-04-10 2013-04-10 IN2014DN08781A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261622330P 2012-04-10 2012-04-10
US201261668923P 2012-07-06 2012-07-06
PCT/US2013/035924 WO2013155152A1 (en) 2012-04-10 2013-04-10 Bis-polymer lipid-peptide conjugates and nanoparticles thereof

Publications (1)

Publication Number Publication Date
IN2014DN08781A true IN2014DN08781A (enExample) 2015-05-22

Family

ID=49328119

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8781DEN2014 IN2014DN08781A (enExample) 2012-04-10 2013-04-10

Country Status (11)

Country Link
EP (1) EP2841083B1 (enExample)
JP (2) JP6426600B2 (enExample)
KR (1) KR20140143838A (enExample)
CN (1) CN104379158A (enExample)
AU (1) AU2013245989B2 (enExample)
CA (1) CA2869984C (enExample)
IL (1) IL235167A0 (enExample)
IN (1) IN2014DN08781A (enExample)
MX (1) MX2014012271A (enExample)
RU (1) RU2014144945A (enExample)
WO (1) WO2013155152A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9949927B2 (en) 2012-04-10 2018-04-24 The Regents Of The University Of California Bis-polymer lipid-peptide conjugates and nanoparticles thereof
WO2016136641A1 (ja) * 2015-02-23 2016-09-01 日本化薬株式会社 生理活性物質結合ブロック共重合体
US10449259B2 (en) 2015-10-02 2019-10-22 Cornell University Enzyme-responsive peptide nanofiber compositions and uses thereof
EP3863609A4 (en) * 2018-10-12 2022-11-16 University of Pittsburgh - Of the Commonwealth System of Higher Education SMALL POLYMERIC CARRIERS FOR DELIVERY OF ACTIVE INGREDIENTS
WO2024260311A1 (zh) * 2023-06-19 2024-12-26 华南理工大学 基于序列固定聚赖氨酸的pH敏感膜裂解材料及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2326893T3 (es) 1998-05-27 2009-10-21 Genzyme Corporation Vectores aav para la fabricacion de medicamentos para administracion potenciada por conveccion.
WO2003022250A2 (en) * 2001-09-10 2003-03-20 Celator Technologies Inc. Unilamellar vesicles stabilized with short chain hydrophilic polymers
WO2009059450A1 (en) * 2007-11-05 2009-05-14 Shanghai Jiaotong University Peptide ligand directed drug delivery
CA2724408A1 (en) * 2008-05-19 2009-11-26 The University Of North Carolina At Chapel Hill Methods and compositions comprising novel cationic lipids
WO2010114632A2 (en) * 2009-04-03 2010-10-07 University Of Houston Metal nanoparticles functionalized with rationally designed coatings and uses thereof
ES2547698T3 (es) * 2009-12-03 2015-10-08 Jiangsu Hengrui Medicine Co., Ltd. Liposoma de irinotecán o su clorhidrato y método de preparación del mismo
WO2011112999A2 (en) * 2010-03-12 2011-09-15 The Regents Of The University Of California Lipid-peptide-polymer conjugates and nanoparticles thereof

Also Published As

Publication number Publication date
JP2015520126A (ja) 2015-07-16
EP2841083A4 (en) 2016-07-13
IL235167A0 (en) 2014-12-31
RU2014144945A (ru) 2016-05-27
MX2014012271A (es) 2015-05-11
WO2013155152A1 (en) 2013-10-17
CN104379158A (zh) 2015-02-25
JP6426600B2 (ja) 2018-11-21
CA2869984A1 (en) 2013-10-17
KR20140143838A (ko) 2014-12-17
CA2869984C (en) 2021-08-17
JP2018150327A (ja) 2018-09-27
EP2841083A1 (en) 2015-03-04
AU2013245989B2 (en) 2017-03-30
AU2013245989A1 (en) 2014-10-30
EP2841083B1 (en) 2020-08-05

Similar Documents

Publication Publication Date Title
CY1126136T1 (el) Μεθοδοι θεραπειας της αρθριτιδας
MX2020000984A (es) Una composicion farmaceutica que comprende nanoparticulas hibridas amorfas estables, de al menos un inhibidor de proteina quinasa y al menos un componente estabilizador polimerico y formador de matriz.
IL259334A (en) Biodegradable lipids for the transfer of active substances
IL238301A0 (en) Attachments for administering medicine containing unnatural amino acids and methods of use
TR201816986T4 (tr) Terapötik ajan iletim formülasyonlarına yönelik lipitler.
MY168297A (en) Cytotoxic Peptides and Antibody Drug Conjugates Thereof
EP2849567A4 (en) CARRIER FOR IMPROVED DRUG DELIVERY
PL2938332T3 (pl) Pre-koncentrat lipidowy analogów gnrh o przedłużonym uwalnianiu i zawierająca go kompozycja farmaceutyczna
NZ709958A (en) Enhanced stability of novel liquid compositions
EP3065722A4 (en) Nucleic acid nanostructures for in vivo agent delivery
EP2807180A4 (en) PEPTIDES FOR CANCER THERAPY
IN2014DN00277A (enExample)
IN2014DN08781A (enExample)
GR1008018B (el) Λιπιδικα συμπλοκα αποτελουμενα απο ανιονικα λυσο-λιπιδια και η εφαρμογη αυτων
TN2013000373A1 (en) Pharmaceutical formulation comprising inositol
PL2605023T3 (pl) Wysokonapięciowy rozdzielacz napięcia i złącze zawierające wymieniony rozdzielacz
MX371297B (es) Una composición farmacéutica que comprende nanopartículas híbridas amorfas estables, de al menos un inhibidor de proteína quinasa y al menos un componente estabilizador polimérico y formador de matriz.
EP2858495A4 (en) VEHICLES FOR RELEASING PESTICIDE COMPOSITIONS
ZA201405925B (en) Pharmaceutical formulation having improved stability
MD4615B1 (ro) Formă solidă izolată de monoclorhidrat de anamorelin, compoziţie farmaceutică şi procedeu de fabricare a formei de dozare farmaceutice care o conţine
LT2638894T (lt) Farmacinė kompozicija, turinti fosfolipido
SG11201504572WA (en) Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
IL237221A (en) Preparations containing analogues of phospholipid drugs
AU340152S (en) Connector for cable
AU2012901190A0 (en) Liposome Compositions and Systems for Drug Delivery